David Meeker
Chief Executive Officer presso RHYTHM PHARMACEUTICALS, INC.
Patrimonio netto: 12 M $ in data 31/03/2024
Provenienza dei contatti di primo grado di David Meeker
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
220
| Non-Profit Organization | Miscellaneous Commercial Services | 220 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
214
| Subsidiary | Medical Specialties | 214 |
57
| Public Company | Pharmaceuticals: Major | 57 |
| Public Company | Biotechnology | 33 | |
| Subsidiary | Pharmaceuticals: Major | 30 | |
| Public Company | Biotechnology | 24 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY.
18
| Extinct | Pharmaceuticals: Major | 18 |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.
18
| Non-Profit Organization | Miscellaneous Commercial Services | 18 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
| Extinct | Pharmaceuticals: Major | 10 | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA.
8
| Holding Company | Pharmaceuticals: Major | 8 |
| Private Company | Financial Conglomerates | 7 | |
Prize4Life, Inc.
 Prize4Life, Inc. Miscellaneous Commercial ServicesCommercial Services Prize4Life, Inc. is a non-profit organization that aims to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig's disease. Prize4Life uses powerful incentives to attract new people and drive innovation in ALS research. The American company believes that out-of-the-box thinking is necessary to find solutions to the biggest challenges in ALS research, and that critical discoveries may come from unlikely places. Prize4Life encourages and rewards creative approaches that will yield real results for ALS patients. The non-profit company was founded by Guy Yamen and Nate Boaz in 2007.
3
| Non-Profit Organization | Miscellaneous Commercial Services | 3 |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David Meeker tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | President Corporate Officer/Principal Treasurer President | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Sales & Marketing | |
| IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Chief Operating Officer Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | President Corporate Officer/Principal Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | President Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Founder | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| University of Glasgow | College/University | Undergraduate Degree Undergraduate Degree | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| George Mason University | College/University | Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Director/Board Member Graduate Degree Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chairman | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member Chief Executive Officer | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal General Counsel | |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chairman Director/Board Member | |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Regno Unito | 3 |
| Paesi Bassi | 3 |
| Svizzera | 2 |
Settori
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 4 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 781 |
| Corporate Officer/Principal | 255 |
| Independent Dir/Board Member | 218 |
| Chairman | 159 |
| Chief Executive Officer | 135 |
Contatti più connessi
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Henri A. Termeer | 42 |
| Todd Foley | 38 |
| Christopher Viehbacher | 37 |
| John Maraganore | 37 |
| Jonathan Fleming | 36 |
| Martijn Kleijwegt | 33 |
| Ted Love | 31 |
| Rémi Droller | 29 |
| Patrick Kron | 28 |
| Steven Holtzman | 28 |
| Jonathan MacQuitty | 27 |
| David Pyott | 27 |
| Mitchell Finer | 26 |
| James Sapirstein | 26 |
- Borsa valori
- Insiders
- David Meeker
- Connessioni Società
